TY - JOUR
T1 - Hapalosin, a Cyanobacterial Cyclic Depsipeptide with Multidrug-Resistance Reversing Activity
AU - Stratmann, Klemens
AU - Burgoyne, David L.
AU - Moore, Richard E.
AU - Patterson, Gregory M.L.
AU - Smith, Charles D.
PY - 1994/12/1
Y1 - 1994/12/1
N2 - Hapalosin (2), a novel cyclic depsipeptide from the blue-green alga (cyanobacterium) Hapalosiphon welwitschii W. & G. S. West (Stigonemataceae), shows MDR-reversing activity. Its structure has been determined to be (3S,4S,8S,9S,12S)-9-benzyl-4-heptyl-8-hydroxy-12-isopropyl-3,10-dimethyl-1,5-dioxa-10-azacyclododecane-2,6,11 -trione by a combination of spectroscopic and chemical methods. The carbon skeleton of 2 was determined by two-dimensional 1H— and 1H—13C NMR correlation experiments and confirmed by mass spectral analysis. The relative and absolute stereochemistry was determined by coupling constant data and Mosher analysis of 2 and three degradation products obtained from acid hydrolysis of 2.
AB - Hapalosin (2), a novel cyclic depsipeptide from the blue-green alga (cyanobacterium) Hapalosiphon welwitschii W. & G. S. West (Stigonemataceae), shows MDR-reversing activity. Its structure has been determined to be (3S,4S,8S,9S,12S)-9-benzyl-4-heptyl-8-hydroxy-12-isopropyl-3,10-dimethyl-1,5-dioxa-10-azacyclododecane-2,6,11 -trione by a combination of spectroscopic and chemical methods. The carbon skeleton of 2 was determined by two-dimensional 1H— and 1H—13C NMR correlation experiments and confirmed by mass spectral analysis. The relative and absolute stereochemistry was determined by coupling constant data and Mosher analysis of 2 and three degradation products obtained from acid hydrolysis of 2.
UR - http://www.scopus.com/inward/record.url?scp=0028598490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028598490&partnerID=8YFLogxK
U2 - 10.1021/jo00103a011
DO - 10.1021/jo00103a011
M3 - Article
AN - SCOPUS:0028598490
SN - 0022-3263
VL - 59
SP - 7219
EP - 7226
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 24
ER -